Recent Finacing
Recent Raise
Orakl operates an AI-driven techbio platform that integrates real‑world clinical and molecular data with biology to build ex vivo patient tumor avatars and predictive models for oncology drug development.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Orakl Oncology.
